Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or <i>BRAF/MEK</i> Targeted Therapy: Multicenter Real-World Report

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or <i>BRAF/MEK</i> Targeted Therapy: Multicenter Real-World Report

Background: The landscape of melanoma management changed as randomized trials have launched adjuvant treatment. Materials and Methods: An analysis of data on 248 consecutive melanoma stage III and IV patients given adjuvant therapy in eight centers (February 2019 to January 2021) was conducted. Resu...

Full description

Bibliographic Details
Main Authors: Joanna Placzke, Magdalena Rosińska, Paweł Sobczuk, Marcin Ziętek, Natasza Kempa-Kamińska, Bożena Cybulska-Stopa, Grażyna Kamińska-Winciorek, Wiesław Bal, Jacek Mackiewicz, Łukasz Galus, Manuela Las-Jankowska, Michał Jankowski, Robert Dziura, Kamil Drucis, Aneta Borkowska, Tomasz Świtaj, Paweł Rogala, Katarzyna Kozak, Anna Klimczak, Paulina Jagodzińska-Mucha, Anna Szumera-Ciećkiewicz, Hanna Koseła-Paterczyk, Piotr Rutkowski
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Cancers
Subjects:
melanoma
adjuvant treatment
targeted therapy
immune check point inhibitors
early-stage melanoma
sentinel node biopsy
Online Access:https://www.mdpi.com/2072-6694/15/17/4384

Internet

https://www.mdpi.com/2072-6694/15/17/4384

Similar Items